Healthcare Industry News:  Elekta 

Devices Litigation

 News Release - March 8, 2021

Elekta wins lawsuit against Livian GmbH

STOCKHOLM, March 8, 2021 -- (Healthcare Sales & Marketing Network) -- Elekta (EKTA-B.ST) announced today that the London Court of International Arbitration (LCIA) has awarded in favor of Elekta in a dispute with Livian GmbH (formerly humediQ GmbH).

The arbitration, reported in the latest interim report (Q3 2020/21), is now finally settled whereby all claims against Elekta group companies are rejected in full.

For further information, please contact:
Mattias Thorsson, VP Corporate Communications
Tel: +46 70 865 8012, e-mail:
Time zone: CET: Central European Time

Cecilia Ketels, Head of Investor Relations
Tel: +46 76 611 76 25, e-mail:
Time zone: CET: Central European Time

About Elekta

For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to - and benefits from - more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit or follow @Elekta on Twitter.

Source: Elekta

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.